Skip to main content

ART Adherence clinical trials at University of California Health

1 research study open to eligible people

Showing trials for
  • Reactive Driven Support for Treatment, Adherence, Resilience, and Thriving (reSTART) Clinical Trial

    open to eligible males ages 18-70

    Men who are living with HIV and use stimulants face many challenges and barriers that may interfere with remembering to take their HIV medication. Forgetting to take HIV medication puts men living with HIV at a greater risk of becoming virally unsuppressed. Researchers are doing this study to test if a remote intervention can help participants improve remembering to take their HIV medications and reduce the HIV viral load among men living with HIV who use stimulants.

    at UCSF

Our lead scientists for ART Adherence research studies include .

Last updated: